neurotransmitters

Unlike in other brain regions, levels of the neurotransmitter decrease in the cerebellum when anxiety is high, suggesting a potential new drug target.

After tackling toxicity and a trial halt, Elena Koundourakis and her team at Takeda are on the cusp of a first-in-class drug for people living with narcolepsy.

The cause of hyperhidrosis, an excessive sweating condition, is enigmatic, but treatment options are plentiful and growing.